Literature DB >> 1707002

Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice.

L Jansson1, T Olsson, B Höjeberg, R Holmdahl.   

Abstract

Development of experimental allergic encephalomyelitis (EAE) in the SJL (H-2s) mice is associated with a T cell-dependent autoimmune response to the C-terminal part of the myelin basic protein (MBP). In this study the influence of both H-2 and non-H-2 genetic background on EAE induced with the MBP89-101 peptide is described. Analysis of different H-2q haplotype strains, B10G, B10Q, SWR and NFR/N, showed that the B10 background is relatively resistant to disease induction. Both SWR and NFR/N were susceptible to EAE showing that the H-2q haplotype is permissive for EAE development induced with MBP89-101 and that the T cell receptor (TcR) haplotype or complement C5 deficiency exert no significant influence on disease susceptibility. In a series of H-2-congenic strains on the B10 background only B10RIII (H-2r) mice were susceptible to EAE. The B10RIII mice developed a severe EAE with early onset and chronic progressive or relapsing course of disease. In addition, B10RIII mice treated with Freund's complete adjuvant and pertussis toxin alone showed an early monophasic disease. The clinical observations were confirmed by immunohistopathologic analysis of the central nervous system. In these studies, we also applied antibodies to different TcR V beta elements which showed no specific limitation of the used TcR among infiltrating T cells in the target tissue in any of the strains. It is concluded that an MBP peptide-specific disease can be induced in three different haplotypes and it is possible that shared structures between the As, Aq and Ar molecules are of importance for the trigger of encephalitogenic T cells with different TcR V elements. The presently described chronic EAE model induced in the B10RIII mice will be of value as a model for multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707002     DOI: 10.1002/eji.1830210323

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Influence of T-cell receptor genes on chronic experimental autoimmune encephalomyelitis.

Authors:  L Jansson; T Olsson; R Holmdahl
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.

Authors:  Albert G Remacle; Jennifer Dolkas; Mila Angert; Swathi K Hullugundi; Andrei V Chernov; R Carter W Jones; Veronica I Shubayev; Alex Y Strongin
Journal:  J Immunol Methods       Date:  2018-02-08       Impact factor: 2.303

3.  Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis.

Authors:  Harley Y Tse; Jinzhu Li; Xiaoqing Zhao; Fei Chen; Peggy P Ho; Michael K Shaw
Journal:  Curr Trends Immunol       Date:  2012

4.  Characteristics of initial and reinduced experimental autoimmune encephalomyelitis.

Authors:  J W Lindsey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1).

Authors:  A S Hansson; D Heinegård; R Holmdahl
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Dissection of a locus on mouse chromosome 5 reveals arthritis promoting and inhibitory genes.

Authors:  Therese Lindvall; Jenny Karlsson; Rikard Holmdahl; Asa Andersson
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

7.  Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

8.  Global and 3D spatial assessment of neuroinflammation in rodent models of Multiple Sclerosis.

Authors:  Shashank Gupta; Regine Utoft; Henrik Hasseldam; Anja Schmidt-Christensen; Tine Dahlbaek Hannibal; Lisbeth Hansen; Nina Fransén-Pettersson; Noopur Agarwal-Gupta; Björn Rozell; Asa Andersson; Dan Holmberg
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

9.  A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation.

Authors:  Freja Aksel Jacobsen; Alexander N Scherer; Jeppe Mouritsen; Hera Bragadóttir; B Thomas Bäckström; Samra Sardar; Dan Holmberg; Anthony J Koleske; Åsa Andersson
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-17       Impact factor: 4.147

10.  Encephalitogenicity of myelin basic protein exon-2 peptide in mice.

Authors:  R B Fritz; M L Zhao
Journal:  J Neuroimmunol       Date:  1994-04       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.